ArticleClinical lymphoma, myeloma & leukemiaPublished
Treatment Patterns, Efficacy, and Tolerability of Belantamab Mafodotin in Patients With Relapsed and/or Refractory Multiple Myeloma: A Real-World Analysis
Regional connection
Verified An author affiliation on the Europe PMC record names GSK. Affiliation source
- Institution
- GSK
- County
- Philadelphia County
Publication record
- Type
- Article
- Venue
- Clinical lymphoma, myeloma & leukemia
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Multiple Myeloma; Neoplasm Recurrence, Local; Treatment Outcome; Retrospective Studies; Adult; Aged; Aged, 80 and over; Middle Aged; Female; Male; Antibodies, Monoclonal, Humanized
- PubMed ID
- 40348718
- Added to directory
- Source checked